Current Medicinal Chemistry

Author(s): Xiaoyan Pan, Chen Wang, Fang Wang, Pengfei Li, Zhigang Hu, Yuanyuan Shan and Jie Zhang

DOI: 10.2174/092986711797287584

DownloadDownload PDF Flyer Cite As
Development of 5-Fluorouracil Derivatives as Anticancer Agents

Page: [4538 - 4556] Pages: 19

  • * (Excluding Mailing and Handling)

Abstract

5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advanced solid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have been performed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, the recent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

Keywords: 5-Fluorouracil (5-FU), anticancer, thymidylate synthase, antimetabolite, toxicity, tumor, derivative, macromolecule, pyrimidine, polymer